Tort Report (Stryker Hips, GranuFlo & NaturaLyte)

by Ben Dozier | July 13, 2012

Upcoming Group Campaigns

Stryker hip implant commercials slated to begin at the end of July.

Recently Added to the Mass Torts Matrix

  • Antibiotic Retinal Detachment
  • Kidney Dialysis Linked to Heart Attacks
  • Reflex Sympathetic Dystrophy/Complex Regional Pain Syndrome
  • Stryker Hip Recall

Developments in the Tort World

  • A study published in The Journal of the American Medical Association has linked fluoroquinolone antibiotics, which are commonly used to treat bacterial infections, to an increased risk of retinal detachment. Retinal detachment is when the retina—the light sensitive tissue in the eye—separates from the other tissues in the eye. This condition typically requires surgery and can lead to blindness if left untreated.
  • The U.S. Food and Drug Administration is investigating whether Fresenius Medical Care failed to properly inform some kidney dialysis patients of their risk of cardiac arrest. The concerns involve the use of Fresenius products GranuFlo and NaturaLyte, which have been linked to alkalosis, a condition associated with an increase in the risk of death and sudden cardiac arrest in patients undergoing dialysis treatment.
  • Complex regional pain syndrome (CRPS), also known as Reflex Regional Pain Syndrome (RSD), is a chronic disorder that causes severe pain, swelling, and changes in skin texture of a person’s hand, arm, foot, or leg. The condition often develops after a traumatic injury such as a car accident, on-the-job accident, or surgical mistake. The condition has no known cure.

For a complete list of the torts we’re tracking, see the Mass Torts Matrix.